University of Wisconsin, Madison
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Wisconsin, Madison sits in the top decile of US sponsors by registered trial count (#31 of 15,742 sponsors by registered trial count).
University of Wisconsin, Madison: 1,039 sponsored US clinical trials, 151 recruiting.
University of Wisconsin, Madison sponsors 1,039 registered US clinical trials on ClinicalTrials.gov, 151 of them currently recruiting, and 712 completed. 98 of these trials are in Phase 3-4 (later-stage) and 251 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 10 trials.
Top-decile sponsor footprint
University of Wisconsin, Madison ranks in the top decile of sponsors by registered trial count (#31 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
712 of 824 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,039 total, page 17 of 21
Mindfulness Meditation for Health
NCT01056484
NCRR ARRA Development-Workforce Development
NCT01184131
Indole-3-Carbinol Effects on Estrogen Metabolism
NCT00988845
Intra-patient Dose Escalation Study of Sorafenib in Advanced Non-small Cell Lung Cancer
NCT00954278
Preliminary Data for Breath Biofeedback of Dietary Compliance
NCT01043783
A Patient-Controlled Cognitive-Behavioral Intervention for Cancer Symptoms
NCT00946803
Efficacy of Injection Therapy for Lateral Epicondylosis
NCT01476605
Treatment for Opioid Dependent Offenders
NCT01082679
Meditation and Exercise for Prevention of Acute Respiratory Infection
NCT01057771
Slow-wave Sleep Deprivation in Depression
NCT01189591
Effects of Positive Energy Balance and Exercise on Appetite Hormones in Sedentary Men and Women
NCT01354600
A Gardening Program to Assess Unhealthy Lifestyle Contributions to Summer Weight Gain in Children
NCT00974727
Safety Study of Adult Stem Cells to Treat Patients With Severe Leg Artery Disease
NCT00913900
Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer's
NCT00980785
Two-Arm Study of a DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) in Patients With Non-Metastatic Castrate-Resistant Prostate Cancer
NCT00849121
The Effect of Vitamin D Statues on Endothelial Function
NCT01049048
DREAM: Does Inhaled Fluticasone REsult in Obstructive Sleep Apnea Manifestations?
NCT01184118
Statin Effects on Beta-Amyloid and Cerebral Perfusion in Adults at Risk for Alzheimer's Disease
NCT00939822
Online and Narrative Interventions for Advanced Cancer Patients
NCT00948207
Pharmacodynamic Study of Axitinib in Patients With Advanced Solid Malignancies
NCT00859118
Computer-Based Alcohol Use Disorder Recovery System
NCT01003119
Long-term Varenicline Treatment for Smoking Cessation
NCT00828113
Effect of ACE-inhibitors on Aortic Stiffness in Elderly Patients With Chronic Kidney Disease
NCT00874432
Bone Microarchitecture in Women With and Without Fracture
NCT01049191
A Pilot Trial to Determine the Efficacy of VSL#3 for Reducing Colonization by VRE
NCT00933556
Observational Trial of Hepatitis C Virus Infected Patients on Calcineurin Inhibitors
NCT00819026
The Effects of Gum Chewing on Energy Intake and Expenditure
NCT01043471
Center for Disease Control (CDC) Fax to Quit/Academic Detailing Grant
NCT00989755
Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors
NCT00582816
Helminth-induced Immunomodulation Therapy (HINT) in Relapsing-remitting Multiple Sclerosis
NCT00645749
Total Xenoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer Rlisk
NCT00839696
Cortico-cortical Connectivity During Midazolam Sedation in Humans; a TMS/EEG Study
NCT00734006
Musculoskeletal Effects of Isotretinoin During Acne Treatment in Pediatric Population
NCT00964119
CP-675,206 in Combination With Short Term Androgen Deprivation in Patients With Stage D0 Prostate Cancer
NCT00702923
Eosinophilic Airway Inflammation and Mepolizumab
NCT00802438
Mobile CHESS Research on Emergency Medical Services for Children
NCT00993590
Cure Rates of Superficial Basal Cell Carcinoma (BCC) EDC
NCT00994240
Functional Magnetic Resonance Imaging (fMRI) of Anosognosia in Amnestic Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)
NCT00908999
Estimating Average Vitamin A Requirements in Indonesian and American Women
NCT04123210
Vitamin A Kinetics and Mathematical Modeling in American Women
NCT03248700
CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma
NCT00634751
Kid STRIDE: Exploring Participation in a Family-based Intervention
NCT00682422
The Effect of Electroacustimulation on Postoperative Nausea, Vomiting and Pain in Outpatient Plastic Surgery Patients
NCT00941005
Does Omeprazole Decrease Intestinal Calcium Absorption?
NCT00582972
Bioenergetic Alterations After Exenatide Administration
NCT00623545
An Initial Study of Lithium in Patients With Medullary Thyroid Cancer
NCT00582712
Pilot hu14.18-IL2 in Resectable Recurrent Stage III or Stage IV Melanoma
NCT00590824
ATM Variants in Radiotherapy Patients
NCT00214227
Mannitol Bronchoprovocation Challenge Ancillary Study/ACRN
NCT00585260
Prevalence of Inpatient Hyperglycemia: Risks, Complications and Outcomes
NCT00585494
What is open in the University of Wisconsin, Madison pipeline
151 recruiting of 1,039 indexed (15% open); 712 completed (69%).
Phase mix: 98 late (III/IV) vs 251 early (I/II) (early-phase heavy).
Top condition: Healthy (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Wisconsin, Madison: open-pipeline peers nationwide
Peers matched on 1,039 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Wisconsin, Madison sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,039 trials (± recruiting share)
- University of Washington · 1,048 trials · 15% recruiting
- Bristol-Myers Squibb · 1,025 trials · 7% recruiting
- University of Florida · 1,106 trials · 15% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Masonic Cancer Center, University of Minnesota · 14% recruiting · 249 trials
- ModernaTX · 14% recruiting · 90 trials
- United States Naval Medical Center, San Diego · 15% recruiting · 41 trials
- The Cleveland Clinic · 14% recruiting · 688 trials
Related
What to do with this University of Wisconsin, Madison page
1,039 registered trials is a research-attention snapshot, not an endorsement of University of Wisconsin, Madison or any single study.
- 151 of University of Wisconsin, Madison's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition University of Wisconsin, Madison studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Wisconsin, Madison pipeline card: 1,039 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.